The pharmacokinetics, pharmacodynamics and tolerability of SHR6508 in chinese healthy subjects: a randomized, placebo-controlled, double-blind, single-dose and dose-escalation phase I trial

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
The pharmacokinetics, pharmacodynamics and tolerability of SHR6508 in chinese healthy subjects: a randomized, placebo-controlled, double-blind, single-dose and dose-escalation phase I trial ; day:16 ; month:12 ; year:2024 ; pages:1-11
Naunyn-Schmiedeberg's archives of pharmacology ; (16.12.2024), 1-11

Creator
Zhang, Sheng-ting
Tan, Hong-yi
Yang, Shuang
Yang, Xiao-yan
Cui, Chang
Huang, Jie
Yang, Guo-ping
Contributor
SpringerLink (Online service)

DOI
10.1007/s00210-024-03705-4
URN
urn:nbn:de:101:1-2502272223092.449751771043
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:26 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Zhang, Sheng-ting
  • Tan, Hong-yi
  • Yang, Shuang
  • Yang, Xiao-yan
  • Cui, Chang
  • Huang, Jie
  • Yang, Guo-ping
  • SpringerLink (Online service)

Other Objects (12)

What does a modified-Fibonacci dose-escalation actually correspond to?

What does a modified-Fibonacci dose-escalation actually correspond to?

PK/PD modeling supports the dose-escalation decision in VIKING

PK/PD modeling supports the dose-escalation decision in VIKING

Phase I dose-escalation oncology trials with sequential multiple schedules

Phase I dose-escalation oncology trials with sequential multiple schedules

Incoherent dose-escalation in phase I trials using the escalation with overdose control approach

Incoherent dose-escalation in phase I trials using the escalation with overdose control approach

Intravesical liposomal tacrolimus for hemorrhagic cystitis: a phase 2a multicenter dose-escalation study

Intravesical liposomal tacrolimus for hemorrhagic cystitis: a phase 2a multicenter dose-escalation study

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Macimorelin in Children with Suspected Growth Hormone Deficiency: An Open-Label, Group Comparison, Dose-Escalation Trial

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Macimorelin in Children with Suspected Growth Hormone Deficiency: An Open-Label, Group Comparison, Dose-Escalation Trial

Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study

Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study

A dose-escalation ex vivo study on the effects of intracameral benzalkonium chloride in rabbits

A dose-escalation ex vivo study on the effects of intracameral benzalkonium chloride in rabbits

Mesenchymal Stem Cell Therapy in Acute Intracerebral Hemorrhage: A Dose-Escalation Safety and Tolerability Trial

Mesenchymal Stem Cell Therapy in Acute Intracerebral Hemorrhage: A Dose-Escalation Safety and Tolerability Trial

Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress

Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress

Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine

Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine

Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study

Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study

Related objects